Literature DB >> 14578624

Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis.

Katsura Kitaura-Inenaga1, Masatake Hara, Kazuhiro Higuchi, Kanjo Yamamoto, Akira Yamaki, Koh Ono, Atsushi Nakano, Makoto Kinoshita, Shigetake Sasayama, Akira Matsumori.   

Abstract

This study examined the gene expression of mouse mast cell proteases to clarify their role in the pathophysiology of viral myocarditis. Male DBA/2 mice were inoculated intraperitoneally with the encephalomyocarditis virus and the gene expression of mast cell chymase, mouse mast cell protease (mMCP)-4 and -5, and tryptase, mMCP-6, matrix metalloproteinase (MMP)-9 and type-I procollagen was measured by real-time quantitative RT-PCR analysis. The gene expression of mMCP-4, -5 and -6 mRNA was increased at 5 days, and continued to increase to day 14, coinciding with a prominent inflammatory reaction and extensive myocardial necrosis and fibrosis. The gene expression of MMP-9 was also increased, and there was a significant correlation between upregulation of mast cell proteases and MMP-9. The gene expression of type-I procollagen was increased at 5 days and continued to increase to day 14, suggesting that a fibrotic process had already begun during the acute stage of viral myocarditis. These findings suggest that mast cell chymase and tryptase participate in the acute inflammation and remodeling process of viral myocarditis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578624     DOI: 10.1253/circj.67.881

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  12 in total

Review 1.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

2.  Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.

Authors:  Stephane Heymans; Florea Lupu; Sven Terclavers; Bjorn Vanwetswinkel; Jean-Marc Herbert; Andrew Baker; Desire Collen; Peter Carmeliet; Lieve Moons
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

Review 3.  Histamine receptors in heart failure.

Authors:  Scott P Levick
Journal:  Heart Fail Rev       Date:  2021-10-08       Impact factor: 4.654

4.  Lessons learned from experimental myocarditis.

Authors:  A Matsumori
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

5.  Cetirizine a histamine H1 receptor antagonist improves viral myocarditis.

Authors:  Akira Matsumori; Kanjo Yamamoto; Miho Shimada
Journal:  J Inflamm (Lond)       Date:  2010-08-04       Impact factor: 4.981

Review 6.  Dilated cardiomyopathy update: infectious-immune theory revisited.

Authors:  Chuichi Kawai; Akira Matsumori
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  Substance P is required for the pathogenesis of EMCV infection in mice.

Authors:  Prema Robinson; Armandina Garza; Jeffrey Moore; T Kris Eckols; Skakun Parti; Vishwanathan Balaji; Jesus Vallejo; David J Tweardy
Journal:  Int J Clin Exp Med       Date:  2009-03-31

8.  Mast cell inhibition attenuates myocardial damage, adverse remodeling, and dysfunction during fulminant myocarditis in the rat.

Authors:  Yair Mina; Shunit Rinkevich-Shop; Eli Konen; Orly Goitein; Tammar Kushnir; Frederick H Epstein; Micha S Feinberg; Jonathan Leor; Natalie Landa-Rouben
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-11-19       Impact factor: 2.457

9.  Association of mast cell-derived VEGF and proteases in Dengue shock syndrome.

Authors:  Takahisa Furuta; Lyre Anni Murao; Nguyen Thi Phuong Lan; Nguyen Tien Huy; Vu Thi Que Huong; Tran Thi Thuy; Vo Dinh Tham; Cao Thi Phi Nga; Tran Thi Ngoc Ha; Yasukazu Ohmoto; Mihoko Kikuchi; Kouichi Morita; Michio Yasunami; Kenji Hirayama; Naohiro Watanabe
Journal:  PLoS Negl Trop Dis       Date:  2012-02-21

Review 10.  Mast Cells: Key Contributors to Cardiac Fibrosis.

Authors:  Scott P Levick; Alexander Widiapradja
Journal:  Int J Mol Sci       Date:  2018-01-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.